Montelukast Prescribing at BEACON MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,793
Total Quantity
119.1K
NHS Cost
£5.7K
vs National Avg
+307.9%
BEACON MEDICAL GROUP prescribed 2,793 items of Montelukast over the last 12 months at a cost of £5,722 to the NHS. This is 307.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
233
Jul 2026
217
Jul 2026
243
Jul 2026
216
Jul 2026
228
Jul 2026
238
Jul 2026
264
Jul 2026
224
Jul 2026
256
Jul 2026
229
Jul 2026
238
Jul 2026
207
Prescribing Details
| Total Items | 2,793 |
|---|---|
| Total Quantity | 119,063 |
| Total NHS Cost | £5,722 |
| Presentations | 4 different forms |
| vs National Average | +307.9% |
Montelukast Prescribing Comparison
| This practice | 2,793 items |
|---|---|
| National average per practice | 685 items |
| Difference | +307.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.